RECRUITING

Development and Assessment of a Spanish-Language Hearing Loss Toolkit for Self-Management

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this application is to develop and evaluate Spanish-language hearing education materials for adults. Our hypothesis is that participants will demonstrate better understanding of their hearing loss and associated difficulties, and will be better able to identify options for self-management following delivery of culturally and linguistically appropriate patient education materials.

Official Title

Development and Assessment of a Spanish-Language Hearing Loss Toolkit for Self-Management

Quick Facts

Study Start:2021-04-22
Study Completion:2024-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04534387

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Participants will include community-dwelling, Spanish-speaking (monolingual or bilingual) adults over age 50 who self-identify as Hispanic/Latino
  2. 2. Clinically-significant hearing loss defined as either greater than 25 decibels hearing leve (dB HL) thresholds at 2 or more frequencies from 250 - 8000 hertz (Hz) and/or significant self-reported hearing difficulties as defined by a score of greater than 8 on the Hearing Handicap Inventory - Screening measure for adults/elderly.
  1. * Individuals who are not fluent Spanish-speakers or who do not self-identify as Hispanic/Latino are not eligible to participate in this study.

Contacts and Locations

Study Contact

Michelle Arnold, Au.D., Ph.D.
CONTACT
813-974-8804
mlarnold@usf.edu
Victoria Sanchez, Au.D., Ph.D.
CONTACT
813-414-3491
vasanchez@usf.edu

Principal Investigator

Michelle Arnold, Au.D., Ph.D.
PRINCIPAL_INVESTIGATOR
University of South Florida
Victoria Sanchez, Au.D., Ph.D.
PRINCIPAL_INVESTIGATOR
University of South Florida

Study Locations (Sites)

University of South Florida
Tampa, Florida, 33620
United States

Collaborators and Investigators

Sponsor: University of South Florida

  • Michelle Arnold, Au.D., Ph.D., PRINCIPAL_INVESTIGATOR, University of South Florida
  • Victoria Sanchez, Au.D., Ph.D., PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-22
Study Completion Date2024-03-30

Study Record Updates

Study Start Date2021-04-22
Study Completion Date2024-03-30

Terms related to this study

Additional Relevant MeSH Terms

  • Hearing Loss